Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDD5Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,907
Award facts
- Contract value 100% obligated
- $10,906.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,906.56 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection) on February 4, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare needs.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle extending through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen, operating as a subsidiary of Cencora, leverages this prime contract vehicle to supply a broad range of medications, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. Forteo is an osteoporosis treatment medication, consistent with the company's extensive portfolio of specialty pharmaceuticals supporting military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FDD5Y?
SPE2DR26FDD5Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FDD5Y worth?
The government has obligated $10,907 on SPE2DR26FDD5Y.
Is contract SPE2DR26FDD5Y an order under another contract?
Yes. SPE2DR26FDD5Y is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDD5Y competed?
The extent of competition for SPE2DR26FDD5Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award